Efficacy of repeat-dose rituximab maintenance therapy for minimal change disease in adults

被引：0
|
作者：
Shinya Taguchi
Takayasu Ohtake
Yasuhiro Mochida
Kunihiro Ishioka
Hidekazu Moriya
Sumi Hidaka
Shuzo Kobayashi
机构：
[1] Shonan Kamakura General Hospital,Kidney Disease and Transplant Center
来源：
Clinical and Experimental Nephrology | 2020年 / 24卷
关键词：
Minimal change disease; Nephrotic syndrome; Relapse; Rituximab; B-cell depletion; Steroid;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1132 / 1139
页数：7
相关论文
共 50 条
  • [31] Comparison of the Efficacy and Safety of Tacrolimus and Low-Dose Corticosteroid with High-Dose Corticosteroid for Minimal Change Nephrotic Syndrome in Adults
    Chin, Ho Jun
    Chae, Dong-Wan
    Kim, Yong Chul
    An, Won Suk
    Ihm, ChunGyoo
    Jin, Dong-Chan
    Kim, Sung Gyun
    Kim, Yong-Lim
    Kim, Yong-Soo
    Kim, Yoon-Goo
    Koo, Ho Seok
    Lee, Jung Eun
    Lee, Kang Wook
    Oh, Jieun
    Park, Jung Hwan
    Jiang, Hongsi
    Lee, Hyuncheol
    Lee, Sang Koo
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (01): : 199 - 210
  • [32] Therapy of relapsing minimal-change disease in adults: a new approach?
    Glassock, Richard J.
    KIDNEY INTERNATIONAL, 2013, 83 (03) : 343 - 345
  • [33] Obinutuzumab May Be an Effective and Safe Option for Adult Minimal Change Disease and Focal Segmental Glomerulosclerosis Patients after Multitarget Therapy Including Rituximab
    Lin, Yuxin
    Pan, Yixuan
    Han, Quan
    Xu, Jianhang
    Wang, Junni
    Lei, Xin
    Chen, Liangliang
    Wang, Yaomin
    Ren, Pingping
    Lan, Lan
    Chen, Jianghua
    Han, Fei
    AMERICAN JOURNAL OF NEPHROLOGY, 2025, 56 (01) : 111 - 120
  • [34] Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?
    Gauckler, Philipp
    Shin, Jae Il
    Alberici, Federico
    Audard, Vincent
    Bruchfeld, Annette
    Busch, Martin
    Cheung, Chee Kay
    Crnogorac, Matija
    Delbarba, Elisa
    Eller, Kathrin
    Faguer, Stanislas
    Galesic, Kresimir
    Griffin, Sian
    Hruskova, Zdenka
    Jeyabalan, Anushya
    Karras, Alexandre
    King, Catherine
    Kohli, Harbir Singh
    Maas, Rutger
    Mayer, Gert
    Moiseev, Sergey
    Muto, Masahiro
    Odler, Balazs
    Pepper, Ruth J.
    Quintana, Luis F.
    Radhakrishnan, Jai
    Ramachandran, Raja
    Salama, Alan D.
    Segelmark, Marten
    Tesar, Vladimir
    Wetzels, Jack
    Willcocks, Lisa
    Windpessl, Martin
    Zand, Ladan
    Zonozi, Reza
    Kronbichler, Andreas
    AUTOIMMUNITY REVIEWS, 2020, 19 (11)
  • [35] Long-term efficacy of maintenance therapy with Rituximab for IgG4-related disease
    Campochiaro, Corrado
    Della-Torre, Emanuel
    Lanzillotta, Marco
    Bozzolo, Enrica
    Baldissera, Elena
    Milani, Raffaella
    Arcidiacono, Paolo Giorgio
    Crippa, Stefano
    Falconi, Massimo
    Dagna, Lorenzo
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2020, 74 : 92 - 98
  • [36] Optimization of Postremission Therapy in Follicular Lymphoma: Efficacy of Rituximab Maintenance
    Roy, Rupali
    Gordon, Leo I.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2011, 9 (05): : 563 - 571
  • [37] Rapid remission of steroid and mycophenolate mofetil (mmf) - resistant minimal change nephrotic syndrome after rituximab therapy
    Yang, Tom
    Nast, Cynthia C.
    Vo, Ashley
    Jordan, Stanley C.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (01) : 377 - 380
  • [38] Induction of remission following a single dose of rituximab alone in a patient with minimal change nephrotic syndrome
    Amemiya, Nobuyuki
    Takei, Takashi
    Kojima, Chiari
    Nokiba, Hirohiko
    Itabashi, Mitsuyo
    Nitta, Kosaku
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2011, 15 (06) : 933 - 936
  • [39] Emerging role of Rituximab in adult minimal change disease: a narrative review of clinical evidence, biomarkers and future perspectives
    Zhong, Anni
    Yu, Yi
    Cao, Tao
    Wan, Qijun
    Xu, Ricong
    BMC NEPHROLOGY, 2025, 26 (01)
  • [40] Diagnosis and treatment of Minimal Change Disease in adults-2023
    Gauckler, Philipp
    Regele, Heinz
    Eller, Kathrin
    Saeemann, Marcus D.
    Lhotta, Karl
    Zitt, Emanuel
    Neumann, Irmgard
    Rudnicki, Michael
    Odler, Balazs
    Kronbichler, Andreas
    Windpessl, Martin
    WIENER KLINISCHE WOCHENSCHRIFT, 2023, 135 (SUPPL 5) : 628 - 637
12345